ODYSSEY THERAPEUTICS

Updated 70 days ago
Private Limited Company
  • Active - 06255507 (CH)
  • Age: 16 years
  • ID: 3316354/152
4242 Campus Point Court San Diego, CA 92121
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
Odyssey Therapeutics is a biotechnology company dedicated to discovering, developing, and commercializing immunomodulators and oncology medicines that aim to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Built from the ground-up by an expert team of drug hunters, scientists and industry leaders, Odyssey is focused on being first to market with programs that act on targets with the highest clinical and commercial potential... Odyssey Therapeutics is developing innovative medicines to make extraordinary leaps in outcomes for patients with cancer inflammatory diseases
Also known as: DEMURIS LIMITED
Previous names: NORHAM HOUSE 1120 LIMITED, NUGENIS LIMITED
Registration numbers: 06255507 (CH)
Primary location: San Diego United States
  • 0
  • 0
Interest Score
1
HIT Score
0.60
CEO
Gary D. Glick
CHRO
Will Smiley
Chief Data Officer
Joseph McDonald
Chief Legal Officer
Kira M. Schwartz
EVP
Kira M. Schwartz
Founder
David Pompliano, Gary D. Glick
President
Gary D. Glick
PublicRelations
me..@odysseytx.com

UK Company Data

Company number
06255507		 Account category
FULL		 Account ref. day
30		 Account ref. month
12
Accounts next due date
2024-09-30		 Accounts last made up date
2022-12-30		 Returns next due date
2017-06-19		 Returns last made up date
2016-05-22
Num. mort. charges
1		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
1
Num. gen. partners
0		 Num. lim. partners
0
Domain
demuris.co.uk
Actual
odysseytx.com
IP
104.21.68.35, 172.67.185.220
Status
OK
Category
Company
0 comments Add a comment